Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
NIH Launches Trial of Hydroxychloroquine, Azithromycin for COVID-19
Trial will enroll 2,000 patients with SARS-COV-2 who have fever, cough, and/or shortness of breath
NIH: Large-Scale Testing of Some COVID-19 Vaccines Could Start in July
About a dozen potential vaccines worldwide are in the initial stages of, or set to begin, testing in people
FDA: Abbott Rapid COVID-19 Test Could Miss Infections
Research has suggested that the Abbott ID NOW point-of-care test may return false-negative results
ACP Advises Against Chloroquine, Hydroxychloroquine for COVID-19
Practice points based on lack of evidence supporting use as prophylaxis or treatment for COVID-19
Interferon-α2b May Shorten Viral Shedding Duration in COVID-19
Duration of elevated blood levels for inflammatory markers IL-6, C-reactive protein also reduced
Addition of Atezolizumab May Aid in Metastatic Urothelial Cancer
Phase 3 trial shows prolonged progression-free survival for atezolizumab plus platinum-based chemo
Autism in Childhood May Up Risk for Later Eating Disorders
Findings seen in longitudinal study of children followed from age 7 to 16 years
Early Diagnosis of Gestational Diabetes Leads to Less Weight Gain
Screening high-risk women for GDM in first trimester optimizes gestational weight gain
T2DM Linked to Worse Cognitive Performance After Stroke
No significant difference found in cognitive function for those with impaired, normal fasting glucose levels
